Tumor antigens recognized by T lymphocytes

Annual Review of Immunology

Volumn 12, Issue , 1994, Pages 337-365

  Boon, Thierry ^b   Cerottini, Jean Charles ^a   Van Den Eynde, Benoît ^b   Van Der Bruggen, Pierre ^b   Van Pel, Aline ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b NONE

Author keywords

cancer; genes; immunotherapy; T lymphocytes; tumor antigens

Indexed keywords

HLA ANTIGEN; TUMOR ANTIGEN;

CANCER; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR REJECTION;

EID: 0028344535     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.iy.12.040194.002005     Document Type: Review

References (22)

1. Gross L. 1943. Intradermal immunization ofC3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 3: 326-33
2. Prehn RT, Main JM. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18: 769-78
3. Klein G. Sjögren H. Klein E, Hellström KE. 1960. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochtonous host. Cancer Res. 20: 1561-72
4. Kripke ML, Fisher MS. 1976. Immunologic parameters of ultraviolet carcinocencsis. J. Natl. Cancer Inst. 57: 211-15
5. Sjögren HO. Hellström I. Klein G. 1961. Resistance of polyoma virus-immunized mice to transplantation of established polyoma tumors. Exp. Cell Res. 23: 204-8
6. Khera KS, Ashkenasi A, Rapp F, Melnick JL. 1963. Immunity in hamsters to cells transformed in vitro and in vivo by SV40. Tests for antigenic relationship among the papovaviruses. J. Immunol. 91: 604 13
7. Klein E, Klein G. 1964. Antigenic properties of lymphomas induced by the Moloney agent. J. Natl. Cancer Inst. 32: 547-68
8. Hewitt H. Blake E, Walder A. 1976. A critique of the evidence for active host defense against cancer based on personal studies of 27 marine tumors of spontaneous origin. Br. J. Cancer. 33: 241-59
9. Middle J. Embleton M. 1981. Naturally arising tumors of the inbred WAB Not rat strain. II. Immunogenicity of transplanted tumors. J. Natl. Cancer Inst. 67: 637-43
10. Boon T. Kellermann O. 1977. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc. Natl. Acad. Sci. USA 74: 272-75
11. Boon T, Van Pel A. 1978. Teratocareinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line. Proc. Natl. Acad. Sci. USA 75: 1519-23
12. Van Pel A. Vessière F. Boon T. 1983. Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J. Exp. Med. 157: 1992-2001
13. Lindenmann J. 1964. Immunity to transplantable tumors following viral oncolysis. I. Mechanism of immunity to Ehrlich ascites tumor. J. Immunol. 92: 912-919
14. Lindenmann J. Klein PA. 1967. Viral oncolysis: increased immunogenidly of host cell antigen associated with influenza virus. J. Exp. Med. 126: 93 108
15. Kobayashi H, Sendo F. Shirai T, Kaji H, Kodama T. Saito H. 1969. Modification in growth of transplantable rat tumors exposed to friend virus. J. Natl. Cancer Inst. 42: 413-19
16. Fearon E, Itaya T, Hunt B, Vogelstein B, Frost P. 1988. Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. Cancer Res. 48: 2975-80
17. Fearon ER, Pardoll DM, Itaya T. Golumbek P. Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P. 1990. Inlerleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60: 397-403
18. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol. 149: 3627-35
19. Hock H, Dorsch M. Kunzendorf U, Qin Z, Diamantstein T and Blankenstein T. 1993. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2. interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc. Natl. Acad. Sci. USA 90: 2774-78
20. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM. 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-16
21. Aoki T, Tashiro K, Miyatakc S-I, Kinashi T, Nakano T. Oda Y, Kikuchi H, Honjo T. 1992. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. Natl. Acad. Sci. USA 89: 3850-54
22. McBride WH, Thacker JD, Comora S, Economou JS, Kelley D, Hoage D, Dubinett SM, Dougherty GJ. 1992. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res. 52: 3931-37